Zydus completes acquisition of 85.6% stake in Amplitude Surgical
Ahmedabad: Zydus Lifesciences Limited has announced the completion of the acquisition of an 85.6 percent stake in Amplitude Surgical.
The deal follows agreements signed on March 11, 2025, between Zydus Lifesciences and PAI, along with two minority shareholders of Amplitude Surgical to acquire blocks of shares representing in aggregate 85.6% of Amplitude Surgical’s share capital and voting rights at a price of €6.25 per share and a total consideration of €256mn (the “Block Acquisition”).
As all conditions precedent to the completion have now been fulfilled, and the Block Acquisition has been subsequently completed on July 29, 2025, Zydus now holds 85.6% of the share capital and voting rights of Amplitude Surgical.
Olivier Jallabert will remain in his role as CEO of Amplitude Surgical, and, as part of the Block Acquisition, has invested into the company which has completed the Block Acquisition.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.